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Numerous  studies  have  shown  that  activation  of T  cells  requires  recognition  of 
antigen  in  association  with  certain  gene  products  of the  major  histocompatibility 
complex (MHC). 1 This so-called MHC  restriction or dual specificity has been shown 
for all  functional  T  cell  subsets  (1-11).  Two  basic  models  have  been  proposed  to 
explain  these  findings:  a  one-receptor or altered-self-model  (12)  and  a  two-receptor 
model (13,  14). The essentials of these models and their variations are well known (10, 
11,  15-18).  In the two-receptor model, it is important to note that the receptors may 
exist either as separate but linked entities or as two distinct subsites of a single complex 
receptor. A critical difference between the two theories is that the two-receptor model 
predicts  that  the T  cell  has specificity  for both  the antigen  and self-MHC  product, 
whereas  the  altered  self-model  predicts  that  the  T  cell  has  specificity  for  neither 
determinant  alone. At the present  time, neither proposal can be totally excluded. 
Several studies exploring the interaction of T  cells with antigen have attempted  to 
block  T  cell  functions  in  vitro  by  the  addition  of excess  free  antigen  (19-26).  In 
general,  these  studies  have  given  negative  results  and  have  been  used  as  indirect 
arguments to support  the altered-self-hypothesis,  Exactly what  influence the in vitro 
conditions  have  on  these  negative  findings  is  unknown.  Ideally,  one  would  like  to 
treat T  cells in vitro with antigen and then measure their functional capacity in vivo, 
under physiological conditions, away from any artifactual  in vitro influence. Contact 
sensitivity (CS) to 2,4-dinitrofluorobenzene (DNFB) is a T  cell-mediated response that 
lends itself to this type of experimentation.  CS is easily transferred  to na~'ve recipients 
with purified T  cells from sensitized donors, and the response can be measured within 
24 h  of transfer  (27). 
Using this  approach,  I  have  investigated  the effect  of treating  DNFB-immune T 
cel~s with  various  monovalent or muEtivalent  2,4-dinitrophenol  (DNP)  ligands.  The 
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results  show  that  treatment  of the  T  cells with  these  ligands  in  vitro  inhibits  the 
transfer of CS to naive recipients. The inhibition is hapten specific, requires divalent 
cations during the treatment  period, and is not due to activation of suppressor cells. 
Furthermore, adsorption studies indicate that anti-idiotypic antibodies and the hapten 
DNP compete for the same site(s) on the immune T  cells. 
Materials and  Methods 
Mice. Female BALB/c mice were obtained from the AMC Cancer Research Center, Lake- 
wood, Colo. Male CBA/J mice were purchased from The Jackson Laboratory, Bar Harbor, 
Maine. 
Haptens, Hapten-Protein Conjugates, and Chemicals.  ~-DNP-L-lysine and  2,4-6-trinitrobenzene 
sulfonate  (TNBS)  were  purchsed  from  Sigma  Chemical  Co.,  St.  Louis,  Mo.  DNFB  and 
2,4-dinitrobenzene sulfonate (DNBS)  were obtained from Eastman Kodak, Rochester, N. Y. 
4-Ethoxy methylene-2-phenyl oxazoione (Ox) was obtained from BDH Chemicals Ltd., Poole, 
Eng.  The  haptens  DNBS  and  TNBS  were coupled  to bovine serum  albumin  (BSA, Mile' 
Laboratories, Elkhart, Ind.), rabbit gamma globulin (RGG, Miles Laboratories), or ammonium 
sulfate precipitated-, Sephadex G-200-purified mouse gamma globulin (MGG)  according to 
the method of Little and Eisen  (28)  and yielded the following coupling ratios: DNPIs-BSA, 
trinitrophenol  (TNP)xg-BSA,  DNPm-RGG,  TNP24-RGG,  and  DNPll-MGG.  The  hapten 
4-hydroxy-3-iodo-5-nitrophenylacetic  acid (NIP) was coupled to MGG according to the method 
of Brownstone et al.  (29)  and yielded a  coupling ratio of NIPg-MGG. Hanks' balanced salt 
solution (HBSS) and Ca  ++, Mg+÷-free HBSS were purchased from Gibco Laboratories (Grand 
Island Biological Co,, Grand Island, N.Y.). 
Sensitization with DNFB or Ox.  To serve as donors of immune lymph node (LN) cells, mice 
were sensitized with DNFB by two daily paintings with 25 #1 of 0.5%  DNFB on the shaved 
abdomen and 5 #1 on the footpads and ears. In some experiments mice were doubly sensitized 
with DNFB and Ox. This was done by painting the left abdomen, forepaw, and ear with DNFB 
(as above), and the right abdomen, forepaw, and ear with 50/xl and 5 p.l, respectively, of 3% 
Ox. 
Transfer of CS.  3 d after the last skin painting, single cell suspensions of draining LN were 
prepared and 4  ×  107 tO 5  ×  10  7 cells injected intravenously into normal syngeneic recipients. 
All recipient groups contained at least four animals. The recipients and negative controls were 
challenged within 1 h after cell transfer by applying 20 p.l of 0.2% DNFB or 20 #1 of 1% Ox on 
the dorsal side of each ear. Increased ear swelling (b') was measured 24 h later with an engineer's 
micrometer and expressed in units of 10  4  in. 
Treatment of Immune LN Cells In Vitro with Hapten Ligands.  Immune LN cells were suspended 
in RPMI  1640 medium (Gibco Laboratories) at  l0  s cells/ml. In some experiments, 1 mg/ml 
BSA was added to the medium. Replicate experiments showed that addition of BSA did not 
affect the results and it was not always used. Various concentrations of the hapten or the carrier 
were  then  added  to  the cell suspensions,  and  the  mixture  incubated  for  1 h  on  ice unless 
otherwise indicated (see Results). The cells were then washed three times, resuspended in RPMI 
medium, and 4 ×  10  7 tO 5 ×  10  7 cells injected intravenously into normal syngeneic recipients. 
Ear challenge and measurement of ear swelling were one as described. The effect of the hapten 
treatment was determined by its ability to inhibit the expression of CS by the tpansferred LN 
cells. The results are expressed as the percent inhibition of transfer compared to untreated or 
carrier-treated immune cells. 
Antiserum.  Anti-Ia  k serum was prepared by repeated injections of A.TH mice with spleen 
and LN cells from normal A.TL donors. The cytotoxicity and specificity of this antiserum has 
been previously described (27).  Monoclonal anti-Lyt-2.2 antibodies were generously provided 
by Dr. Kappler and Dr. Marrack from National Jewish Hospital. This reagent was obtained 
from a hybridoma cell line produced by Dr. Paul Gottlieb (30). The cytotoxicity and specificity 
of this monoctonal antibody has been described in detail (30).  For treatment of immune LN 
cells, 10  s cells/ml were suspended in  l:10 diluted anti-la  k or 1:400 anti-Lyt-2.2 and incubated 
for 1 h at 4°C. This dilution of anti-Lyt-2.2 eliminates suppressor cell activity in LN cells from 
mice  injected  intravenously  with  DNP-coupled  syngeneic  spleen  cells  (not  shown).  After JOHN  W.  MOORHEAD  1813 
washing, anti-la-treated cells were resuspended  in  1:20 rabbit complement  (C) and anti-Lyt- 
treated cells were resuspended in  1:6 guinea pig C  and incubated for  10 min at 4°C and then 
30 min at 37°C. The washed cells were then resuspended in RPMI medium at  l0  s cells/ml and 
treated with hapten. 
Purification of T  Cells.  Lymph  node T  cells were purified on nylon wool according to the 
method of  Julius et al. (31). 4-5 ×  10  s LN cells in 1.0 ml were washed into 1.5-2.0-g nylon wool 
columns  with  warm  medium,  and  the  columns  were  incubated  at  37°C.  After  20  min 
incubation, the cells were slowly moved down the column by allowing 0.5-1  ml of medium to 
pass through.  The column was replaced at  37°C  and after an additional 20 min incubation, 
the  above  procedure  was  repeated.  After  a  total  incubation  period  of  60  min  at  37°C, 
nonadherent cells were collected by washing the column slowly with 25-30 ml of warm medium. 
The  eluted  cells  were  washed  and  resuspended  at  l0  s  cells/ml  in  RPMI  medium.  The 
nonadherent T  cells were monitored for B  cell contamination by immunofluorescent staining 
with fluorescein-labeled polyvalent rabbit anti-mouse Ig and for macrophage contamination 
by  esterase  staining.  In  the  experiments  reported  here  (Table  III  and  VIII),  the  T  cell 
populations contained a  maximum of 1% B cells and <1% macrophages. 
Results 
Dose-dependent Inhibition by DNP-Lysine of Transfer of CS.  To  determine  whether 
soluble  hapten  would  interfere  with  transfer of CS,  DNFB-immune  LN cells were 
incubated  for  1 h  at 4°C  with  different concentrations  of monovalent DNP-lysine. 
The  cells  were  then  washed  to  remove  free  hapten  and  5  ×  107  cells  injected 
intravenously  into  each  of four syngeneic recipients.  These  animals were  then  ear 
challenged, and ear swelling was measured 24 h  later. Results of two experiments are 
given in Table I and show a  dose-dependent  inhibition by DNP-lysine of transfer of 
CS  to  DNFB.  Similar  inhibition  curves  have  been  obtained  using  DNP-glycine, 
DNPI1-MGG, DNPIs-BSA, and DNP~a-RGG (not shown). 
Specificity of Hapten-mediated Inhibition of Transfer of Immunity.  To test the specificity 
of inhibition,  we compared various DNP-, TNP-, and NIP-protein conjugates.  The 
treatment protocol was the same. Immune LN cells (10a/ml) in RPMI medium were 
TABLE  I 
Dose-dependent Inhibition  by DNP-Lysine of Transfer of CS to DNFB 
Group 
Pretreatment  Experiment I  Experiment II 
of immune 
LN cells with  lnhibi-  Inhibi- 
DNP-lysine  A Ear swelling*  tion  A Ear swelling  tion 
A 
B 
C 
D 
E 
t~g/lOScells/  X  lO-4 in.  X  lO-4  in.  %  % 
ml  ± SEM  ± SEM 
--  25.0 +  2.8  33.6 ±  3.1 
0.1  19.9 ±  3.4  20  21.0 ±  3.0:1:  38 
1.0  9.9 ±  1.1§  60  9.4 ±  2.1§  72 
10.0  0.2 ±  1.2§  99  2.3 ±  1.1§  93 
100.0  1.1  +  0.7§  96  2.0 ±  0.9§  94 
BALB/c mice were sensitized with DNFB on days 0 and 1, and immune LN cells harvested 
on day 4. The cells were resuspended in RPMI  1640 medium at  10  s cells/ml and treated 
with different doses of DNP-lysine for 1 h at 4°C. The cells were then washed three times 
and  transferred  to  normal  syngeneic  recipients that  were  ear  challenged with  DNFB. 
Increased ear swelling was measured 24 h later as an index of transfer of CS. 
* Ear swelling in recipients of immune LN cells minus ear swelling in negative controls (ear 
challenge only). 
:~ P <  0.05. 
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treated  for  1 h  at 4°C  by the addition  of 1 /tg/ml of the particular  hapten-protein 
conjugate.  A  group  of cells  treated  with  1 gg/ml  DNP-lysine  was  included  in  all 
experiments for comparison. After washing, 5 ×  107 cells were injected intravenously 
into naive recipients that were then ear challenged, and ear swelling was measured 24 
h  later.  Representative results of several replicate experiments are given in Fig.  1. In 
experiment  I,  pretreatment  of  the  immune  LN  cells  with  either  DNP-lysine  or 
DNPla-MGG inhibited the transfer of immunity by >60%  (compare groups B and C 
with A), whereas treatment of the LN cells with NIPa-MGG had no effect (compare 
groups D  and A).  Similar results were obtained  in experiment  II where  DNP- and 
TNP-protein conjugates were compared. Pretreatment with DNP-lysine, DNPa~-BSA, 
or DNP29-RGG inhibited transfer by 75% or more (compare groups B, C, and E with 
A).  In  contrast,  treatment  with  TNP19-BSA  or  TNP24-RGG caused  no  significant 
inhibition  (compare groups D  and F with A). 
To  examine  the  specificity  of inhibition  in  a  more  critical  way,  the  following 
experiment was done. BALB/c mice were doubly sensitized with DNFB and Ox (see 
Materials and Methods). A single cell suspension of pooled LN was prepared, diluted 
to  10  s cells/ml, and divided into two tubes. One tube received  1 #g/ml DNP-lysine 
and the other received an equal amount of lysine. After  1 h  at 4°C, 5 ×  107 washed 
cells were injected intravenously into normal syngeneic recipients. Half of the recipi- 
ents that received control lysine-treated LN cells and half that received DNP-lysine- 
treated  cells  were  ear  challenged  with  DNFB.  The  remaining  recipients  were  ear 
challenged with Ox. Increased ear swelling was measured 24 h  later.  Results of two 
such experiments are given in Table II. Transfer of contact sensitivity to DNFB by 
LN cells  from the  doubly  sensitized  mice was  inhibited  by treating  the  cells  with 
DNP-lysine (compare group B with A). In contrast, the ability of these same LN cells 
to  transfer  contact  sensitivity  to  Ox  was  unaffected  by the  DNP-lysine  treatment 
(compare groups C  and D). Collectively, these results indicate that the inhibition of 
transfer  of  CS  by  treating  immune  LN  cells  with  DNP-lysine  or  DNP-protein 
conjugates is hapten specific. Furthermore, the results in Table II show that the  1-h 
A  Ear  Swelling 
1" 
Trutrmmt  of 
.Group  LN  Ceils 
A  None 
B  DNP-Lysine 
C  DNPll-MGG  ~f 
D  NIPe-MGG 
A  None 
B  DNP-Lyslne 
B 
C  DNPw'BSA  ~  * 
D  TNI~-BSA  b.  E  DNR4rRGG 
F  TN~4.RGG 
11 
o  ~  x  m  .N 
k 
1.  |  ! 
I  I  n 
|,,,  •  : 
Ft¢.  1.  Hapten specificity of inhibition of transfer of immunity. BALB/c mice were sensitized with 
DNFB on days 0  and  1, and immune LN cells  harvested on day 4. The cells  were suspended in 
RPMI  medium at  10  s cells/ml and  treated  for  t  h  at  4°C  with  either  DNP-lysine or different 
DNP-, NIP-, or TNP-protein conjugates. The ceils were then washed three times and 5 ×  107 cells 
transferred intravenously into normal recipients (four per group). The recipients were ear challenged 
with DNFB, and ear swelling was measured 24 h later. * P <  0.01. JOHN  W.  MOORHEAD  1815 
TASLE  II 
Specificity of DNP-Lysine Inhibition of Transfer of CS to DNFB 
Group 
LN  Treatment of LN  Experiment I  Experiment I[ 
ceils  cells from  Challenge 
trans-  DNFB-  plus Ox-  antigen  A Ear  Inhibi-  A Ear swelling  Inhibi- 
ferred  sensitized  mice  swelling*  tion  tion 
x  107  x  10 .4 in.  X  tO -4 in.  % 
:t: SEM  %  + SEM 
A  5.0  Lysine  DNFB  23.7 +  1.8  43.7 ± 4.1 
B  5.0  DNP-lysine  DNFB  9.9 +  1.6:1:  60  9.6 + 2.3:]:  79 
C  5.0  Lysine  Ox  38.9 + 4.0  47.0 + 4.6 
D  5.0  DNP-lysine  Ox  43.6 ::1:3.1  0  53~2 ± 3,9  0 
BALB/c mice were doubly sensitized with DNFB and Ox on days 0 and 1, and immune LN cells were 
harvested and pooled on day 4. The cells were suspended in RPMI  1640 medium at  l0  s cells/ml, and 
half of the total population were treated with I g,g/ml DNP-lysine for  I h at 4°C. Control cells were 
treated with 1/~g/ml lysine.  The cells were then washed and transferred to normal syngeneic  recipients. 
Half of the recipients that received control LN cells and half that received DNP-lysine  treated cells were 
ear challenged with DNFB. The remaining recipients were challenged with Ox. Increased ear swelling 
was measured 24 h later as an index of transfer of immunity. 
* See footnote in Table I. 
~: P< 0.001. 
treatment with  the  monovalent hapten  is  not  toxic  for the  LN cells since only the 
DNP-specific response is inhibited. 
DNP-Lysine Inhibits  T  Cells  That Are Ia-.  CS to DNFB can be transferred to naive 
recipients by Ia- LN T  cells (27). Thus, experiments were done to determine whether 
purified Ia- T  cells were hapten inhibitable. Results of these experiments are given in 
Table  III.  In  experiment  I,  unseparated  and  nylon wool-purified DNFB-immune 
BALB/c LN T  cells were compared.  Both cell populations transferred similar levels 
of immunity and both were sensitive to inhibition by the hapten. In experiment II, 
purified LN T  cells from DNFB-immune CBA mice were treated with normal mouse 
serum or anti-Ia  k serum plus C  and then tested for their sensitivity to inhibition by 
hapten.  Antiserum treatment did not alter either the ability of the cells to  transfer 
immunity or their sensitivity to inhibition by DNP-lysine. These results indicate that 
inhibition  of transfer of immunity is mediated by interaction of the hapten DNP with 
the effector T  cells of the CS reaction. 
Hapten-mediated  Inhibition  of Transfer of Immunity  Is  Not  due  to  Activation  of Suppressor 
Cells.  Skin  painting  of  mice  with  DNFB  induces  at  least  two  distinct  T  cell 
subpopulations: effector T  cells of the CS reaction (Ton) and auxiliary suppressor T 
cells (Ts-aux)  (32).  This latter population is required for suppression of the efferent 
limb of CS by suppressor T  cells (32).  Because the immune LN cells contain both T 
cell  subsets,  it  was  possible  that  inhibition of  transfer  of  immunity was  due  to 
activation of Ts-aux cells by the hapten. To test this possibility, cotransfer experiments 
were done. Immune LN cells were prepared and a  portion treated with DNP-lysine. 
After washing, half  of the treated cells were injected intravenously  into naive recipients 
(5 ×  107/recipient). The remaining cells were mixed with untreated immune LN cells 
(1:1) and  10  s cells injected into nai've recipients. A  third group of recipients received 
5  ×  107  untreated  immune LN  cells.  All  mice  were  then  ear  challenged, and  ear 
swelling was measured 24  h  later.  As shown in Table IV, cotransfer of DNP-lysine- 1816  HAPTEN  INttIBITION OF  DNFB-IMMUNE T  CELLS 
TABLE  III 
Transfer of CS by Purified DNFB-immune  T  Cells Is Inhibited by DNP-Lysine 
Exp. 
DNFB- 
im- 
mune 
LN 
cells 
trans- 
ferred 
Serum treatment  DNP-ly- 
sine 
Experiment I  Experiment II 
A Ear swell-  Inhibi-  A Ear swell-  Inhibi- 
ing*  tion  ing  tion 
II 
1 g,g/lO  ~  ×  IO -4 in.  ×  10 -4 in.  %  % 
cells/rnl  +  SEM  -i- SEM 
Unseparated  None  -:~  29.6 4- 2.0  36.0 ::t: 3.0 
Unseparated  None  +  8.4 +  0.9§  72  11.7 ±  2.0§  68 
Purified T  cells  None  -  25.4 ±  1.9  34.8 4-  1.3 
Purified T  cells  None  +  3.1  ±  l. 1§  88  8.7 ±  0.7§  75 
Purified T  cells  NMSt] +  C  -  37.8 ±  4.2  27.4 ±  3.0 
Purified T  cells  NMS+C  +  12.1 +2.0§  68  4.1  ±  1.0§  85 
Purified T  cells  Anti-Ia¶ +  C  -  39.3 ±  2.7  27.2 ±  2.5 
Purified T  cells  Anti-la +  C  +  9.2 ±  1.7§  77  4.9 4- 2.2§  82 
BALB/c (experiment I) or CBA (experiment II) mice were sensitized with DNFB on days 0 and  l, and 
immune LN cells, harvested on day 4. In experiment I, a portion of the cells were purified on nylon wool 
colunms. Unseparated and purified T  cells were suspended in RPMI  1640 medium at  108 cells/ml, and 
half of each population were treated with 1 ~g/ml DNP-lysine for 1 h at 4°C. The cells were then washed 
three times and transferred to normal syngeneic recipients. 
* See footnote in Table I. 
:]: 1 #g/ml lysine. 
§ P <  0.001. 
]] Normal mouse serum. 
¶ Anti-la  k serum. 
TABLE IV 
DNP-Lysine Inhibition of Transfer of CS to DNFB  Is Not Due to Suppressor Cells 
Group 
DNP-  Experiment I  Experiment II 
Untreated  lysine- 
immune  treated 
Inhibi-  Inhibi- 
LN  immune  A Ear swelling*  tion  A Ear swelling  tion 
LN 
X  [07  X  ]07  ?K  10 -4 in.  + SEM  %  ×  lO -4 in. +. SEM  % 
A  5.0  --  41.8 +  3.6  54.2 +  3.3 
B  --  5.0  9.1  4-  1.7:~  78  14.6 +  3.1~  73 
C  5.0  5.0  39. l  +  2.7  7  64.6  +  5.6  0 
BALB/c mice were sensitized with DNFB on days 0 and  1, and immune LN cells were harvested on day 
4. The cells were suspended in RPMI  1640 medium at  108 cells/ml and a  portion treated with  1 #g/nd 
DNP-lysine for 1 h at 4°C. These cells were then washed three times, and half were injected into normal 
syngeneic recipients. The remaining cells  were mixed with an equal number of untreated  immune LN 
cells,  and  the  mixture  injected  into  normal  syngeneic  recipients.  An  additional  group  of recipients 
received only untreated immune cells.  All  animals were ear challenged, and increased ear swelling was 
measured 24 h later as an index of transfer of immunity. 
* See footnote in Table I. 
:~ P <  o.00 I. 
treated  cells  with  untreated  immune  cells  had  no  effect  on  the  ability  of the  latter 
population  to transfer immunity. 
To  further  test  for the possible role of suppressor  T  cells,  the  following experiment JOHN  W.  MOORHEAD  1817 
was  done.  Immune  LN  cells were  prepared,  and  four  replicate tubes  were  treated 
with monoclonal anti-Lyt-2.2 antibody plus C. The washed cells were resuspended at 
l0  s cells/ml in RPMI  medium, treated for 1 h  at 4°C with lysine or DNP-lysine, and 
then  tested for their ability to transfer CS.  Results of two experiments are given in 
Table V  and show that  anti-Lyt-2.2 plus C  treatment did not alter the sensitivity of 
the  LN  cells  to  inhibition  by  DNP-lysine.  These  results  indicate  that  DNP-lysine 
inhibition of transfer of CS is not due to activation of suppressor cells. 
Effect  of Temperature,  Time of Treatment,  and Divalent  Cations  on  DNP-Lysine  Inhibition. 
Certain in vitro conditions have been found to be critically important for studying T 
cell interaction with antigen. Thus, experiments were done to determine the minimal 
in  vitro conditions necessary for DNP-lysine-mediated inhibition of transfer.  Three 
parameters were examined and representative results are given in Table VI. First, the 
temperature during the incubation period was tested. Immune LN cells (10  s cells/mi) 
were incubated with  1 #g/ml DNP-lysine for 1 h  at 4 °, 22 °, and 37°C. Lysine-treated 
cells were incubated at 37°C.  After washing, the cells were tested for their ability to 
transfer CS.  As shown  in experiment I, incubation temperature had no effect on the 
ability  of  DNP-lysine  to  inhibit  transfer  of  immunity.  Next,  we  determined  the 
minimum amount of time necessary to treat the cells. Replicate tubes of immune LN 
cells (10  s cells/ml)  were  treated with  1 #g/ml  DNP-lysine at  4°C  for  15,  30,  or 60 
min, washed, and 5 ×  107 cells transferred to naive recipients. As shown in experiment 
II, significant inhibition of transfer was obtained by treating the cells for only 15 min 
(compare group B  to A). Finally, we examined the requirement  for divalent cations. 
Immune  LN  cells were  suspended  in  HBSS  or  in  Ca  ++,  Mg++-free  HBSS  at  l0  s 
cells/ml  and  treated  for  1  h  at  4°C  with  1 #g/ml  DNP-lysine.  Control  cells were 
treated with lysine and incubated in Ca  ++, Mg++-free HBSS. After washing, 5  ×  107 
cells per recipient were transferred to nai've recipients, and ear swelling was measured 
24  h  later. As shown  in experiment  III, transfer to CS by immune  LN cells treated 
TABLE V 
Lyt-2 + T  Cells Are Not Required for DNP-Lysine Inhibition  of Transfer of CS 
Serum treatment of  DNP- 
Group  immune LN  lysine 
Experiment I  Experiment II 
A Ear  Inhibi-  Inhibi- 
swelling*  tion  A Ear swelling  tion 
I~g/lO s  ×  10 -4 in.  ×  10 -4 in.  %  % 
cells/ml  ± SEM  ± SEM 
A  Anti-Lyt-2.2 + C  -:l:  27.0 + 2.0  21.0 +  1.4 
B  Anti-Lyt-2.2 + C  1  6.2 ±  1.3§  77  ND[I 
C  Anti-Lyt-2.2 + C  10  10.2 ±  1.0§  62  9.7 ±  1.5¶  54 
D  Anti-Lyt-2.2 + C  100  5.2 ± 0.5§  81  4.3 ± 0.8§  80 
BALB/c mice were sensitized with DNFB on days 0 and 1. Immune LN cells were harvested on day 4 
and treated with  monoclonal anti-Lyt-2.2  (1:400) plus C. The cells were then  treated with  different 
concentrations of DNP-lyslne for 1 h at 4°C, washed and transferred to naive recipients. The recipients 
were ear challenged with DNFB, and ear swelling was measured 24 h later. 
* See footnote in Table I. 
:1:10 #g/ml lysine. 
§ P< 0.001. 
H  Not done. 
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TAaLE  VI 
Effect of Different In  Vitro Conditions on DNP-Lysine Inhibition  of Transfer 
of CS to DNFB 
Experi-  Group  Treatment of immune LN cells  A Ear  Inhibi- 
ment  before transfer  swelling*  tion 
X  10 -4 in.  % 
+ SEM 
I  A  Lysine--37°C  42.2 + 3.8 
B  DNP-lysine--4°C  13.6 +  2.6:~  68 
C  DNP-lysine--22°C  12.8 ± 2.8~:  70 
D  DNP-lysine--37°C  11.2 ~  3.0~:  74 
II  A  Lysine--4°C, 60 rain  24.0 ±  1.3 
B  DNP-lysine--4°C, 15 rain  14.9 ± 2.4§  38 
C:  DNP-lysine--4°C, 30 min  1.8 ±  1.8:~  93 
D  DNP-lysine--4°C, 60 min  3.1 ± 2.2:~  88 
IIl  A  Lysine in Ca  ++, Mg++-free HBSS  30.4 + 3.6 
B  DNP-lysine in HBSS  6.3 ±  2.11:  80 
C  DNP-lysine in Ca  ++, Mg++-free HBSS  28.5 ±  3.2  6 
BALB/c mice were sensitized  were DNFB on days 0 and  1 and immune LN cells were 
harvested  on day 4.  In experiments I  and II the cells were suspended in RPMI  1640 
medium at  10  s cells/ml and treated with  1 #g/ml DNP-lysine or lysine as indicated. In 
experiment III cells were suspended in HBSS or Ca  ++, Mg++-free HBSS at  10  a cells/ml 
and treated with  1 #g/ml DNP-lysine or lysine for  1 h at 4°C. In all three experiments, 
after treatment the cells were washed  three times and transferred  to ha'ire recipients  that 
were then ear challenged.  Increased  ear swelling was measured  24 h later as an index of 
transfer of immunity. 
* See footnote in Table I. 
~: P< 0.001. 
§ P <  0.05. 
with  DNP-lysine in Ca ++, Mg++-free  HBSS  was  not inhibited (compare  group  C  to 
A), whereas the transfer by cells treated  in HBSS containing divalent cations (group 
B)  was  inhibited by 80%.  Collectively, these  results  indicate that  the  interaction of 
DNP-lysine with immune LN T  cells in vitro is rapid, temperature independent, and 
requires the presence of divalent cations in the treatment medium. 
DNP-Lysine Inhibition of DNFB-immune  T  Cells Is Reversible.  To begin to explore the 
mechanism  of  the  hapten  inhibition,  two  possibilities  were  considered.  First,  the 
hapten  may  bind to  receptors  for  DNP  and  block the T  cell  from  interacting with 
immunogenic  forms  of  DNP  in  association  of  MHC  gene  products,  i.e.,  receptor 
blockade.  Alternatively,  interaction with  hapten  alone  may  provide  some  negative 
signal  to  the  T  cell,  making  it  refractory  to  stimulation.  If so,  the  cells  should  not 
become  functional after  a  short  incubation period  in  vitro  in  hapten-free  medium. 
However, if inhibition is due to hapten blocking the receptor, then incubation in vitro 
may reverse the effect  by allowing the hapten to dissociate from  the cell surface.  To 
attempt  to distinguish between these two possibilities, the following experiment was 
done. Four replicate tubes of immune LN cells were treated with DNP-lysine in vitro 
according  to  the  standard  protocol.  After  washing,  one  group  of cells was  injected 
intravenously  into  syngeneic  recipients.  The  remaining  cells  were  resuspended  in 
RPMI  medium and incubated at 37°C for  1 h. These cells were then washed and one 
group was injected intravenously into syngeneic recipients. The remaining two tubes 
of cells were resuspended  in RPMI  medium, placed at  4°C, and one tube was again JOHN  W.  MOORHEAD  1819 
treated  with  1 #g/ml of DNP-lysine. After  1 h  incubation, these cells were washed 
and transferred to na'ive recipients. Control, lysine-treated immune cells were carried 
through  all  three  incubation periods  and  then  injected  into  recipient  mice.  All 
recipients were then ear challenged, and ear swelling was measured 24 h  later. The 
results are given in Table VII. Immune LN cells treated for 1 h with DNP-lysine and 
then transferred were inhibited (compare group B to A). This inhibition was reversed 
by incubating  the treated cells for 1 h at 37°C in hapten-free medium (compare group 
C  with A  and B). However, if similarly treated cells were reincubated at 4°C for  1 h 
and retreated  with  DNP-lysine, their ability to  transfer immunity was  once again 
inhibited (compare group E  to A  and D). These results favor the interpretation that 
the inhibition is mediated by hapten binding to the T  cell receptors thus blocking the 
cell from interacting with antigen-presenting  cells at the skin test site. 
Additional experiments have shown that this reversal of inhibition is temperature 
independent, i.e., reversal occurs if the treated cells are incubated for  1 h  in hapten- 
free  medium at  4 °,  25 °,  or  37°C.  Also, we  have  found that  addition of fetal  calf 
serum  (FCS)  to  the  hapten-free  medium  retards  the  reversal  in  a  concentration- 
dependent way. In other words, hapten-treated immune LN cells incubated for 1 h at 
37°C in hapten-free medium containing 20% FCS are still inhibited by 50% or more, 
whereas cells incubated in medium containing 10 or 5%  FCS are progressively less 
inhibited (data not shown). 
Competition  of DNP-Lysine and Anti-Idiotype Antibodies for Binding Sites on DNFB-immune 
T  Cells.  Previous studies from our laboratory have shown that the duration of the 
CS response to DNFB is regulated by anti-idiotype antibodies produced by the host 
TABLE VII 
Inhibition by DNP-Lysine of Transfer of CS to DNFB Is Reversible by Incubating the 
Treated Cells In  Vitro 
3rd treatment  Experiment  I  Experiment It 
2nd treatment  of im- 
Ist treatment  of immune  of immune 
Group  LN cells (4°C)  mune LN cells  LN cells  A Ear swell-  A Ear swell- 
(37°C)  Inhibition  Inhibition 
(4°C)  ing*  ing 
X  10  -4 in.  X  10  -4 m. 
% 
+  SEM  +  SEM 
A  Lyslne  None  Lysine  50.7 +  3.9  34.4 ±  3,6 
B  DNP-lysine  (cells  injected  19.2  ±  1.4~  62  7.5 ±  2.S:~  78 
after  Ist treatment) 
C  DNP-lysine  None  (cells injected  47.2 ±  3.6  7  31.6 ±  3.0  8 
after  2nd  treat- 
ment) 
13  DNP-lyslne  None  None  44.8 :k 3.1  1 I  31. I +  3.3  10 
E  DNP-lysine  None  DNP-lysine  15.3  ±  3.1~:  70  11.2  ±  1.9~  67 
BALB/c mice were sensitized with DNFB on days 0 and 1, and immune LN cells harvested on day 4. 
The cells were suspended in RPMI 1640 medium at l0  s cells/ml and aliquoted into five replicate tubes. 
Cells in tube A were carried through all three  l-h  incubations and treated with  1 #g/ml lysine as 
indicated. Tubes B-E were initially treated with 1 #g/ml DNP-lysine at 4°C and washed. Cells in tube 
B were then injected intravenously into syngeneic recipients. Cells in tubes C-E were resuspended in 
RMPI  1640 medium, incubated for 1 h at 37°C, and washed. Cells in tube C were then injected into 
syngeneic recipients. Cells in tubes D and E were then resuspended in RPMI  1640 medium, 1 ~g/ml 
DNP-lysine  added to tube E, and the two tubes incubated for 1 h at 4°C. After washing, these cells plus 
the cells from tube A were injected intravenously into three groups of syngeneic  recipients. All recipients 
were then ear challenged with DNFB, and increased ear swelling  was measured 24 h later. 
* See footnote in Table I. 
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(33). Suppressive immune serum (SIS) which contains these antibodies is obtained by 
bleeding DNFB-immune mice 9-15 d  after sensitization.  Treatment of immune LN 
cells with SIS plus C eliminates transfer of CS to DNFB but has no effect on transfer 
of immunity to TNCB or Ox. Similarly, the anti-idiotype activity of SIS is removed 
by adsorption with DNFB-immune LN ceils but not by TNCB- or Ox-immune cells 
(33). We used this adsorbing ability of DNFB-immune LN cells to determine whether 
DNP-lysine  and  anti-idiotypic  antibodies  were  binding  to  the  same  sites  on  the 
immune T  cells. The following protocol was used. Nylon wool-purified or unseparated 
immune LN cells were treated  in  vitro for  1 h  at 4°C  with hapten.  After washing, 
2 ×  10  a treated or control cells were used to adsorb 2 ml of 1:2 diluted SIS for 30 min 
at 4°C. To test for remaining anti-idiotype activity, freshly prepared DNFB-immune 
LN cells were then treated with adsorbed or unadsorbed SIS plus C  and transferred 
to naive recipients. These animals were ear challenged, and ear swelling was measured 
24 h  later. Results of these experiments are shown in Table VIII. Two different pools 
of SIS were used in the two experiments shown. In experiment I, untreated and DNP- 
lysine-treated nylon wool-purified DNFB-immune LN T  cells were compared for their 
ability to adsorb SIS. Unadsorbed SIS plus C  inhibited transfer of immunity by 71% 
(compare  group  B  to  A),  whereas  serum  adsorbed  with  lysine-treated  LN T  cells 
inhibited transfer by only 12% (compare group C  to A). In contrast, serum adsorbed 
with  DNP-lysine-treated  T  cells  inhibited  transfer by 68%  (group  D  vs.  A).  Thus, 
DNP-lysine treatment of the T  cells blocked their ability to adsorb the activity of the 
SIS.  In experiment  II, the specificity of the  inhibition  of adsorption  was tested  by 
comparing immune LN cells treated with DNP-lysine, DNPn-MGG, or NIPg-MGG. 
This SIS was somewhat less active as the unadsorbed serum plus C  inhibited transfer 
TABLE VIII 
Adsorption of Anti-Idiotype Antibody by DNFB-immune  T Cells Is Blocked by Pretreating the Cells with 
DNP-Lysme or DNPu-MGG 
Serum  Experiment I  Experiment II 
Group  treatment of  Serum preadsorbed 
immune  with  A Ear  Inhibi-  A Ear  Inhibi- 
LN ceils  swelling*  tion  swelling  tion 
×  I0 -4 in.  X  10 -4 in.  %  % 
+  SEM  ±  SEM 
A  NMS, +  C  None  44.8 ±  4.1  29.2 +  2.6 
B  SIS +  C  None  13.0 ±  1.9§  71  16.3 ±  2.611  44 
C  SIS +  C  Lysine-treated TD.  39.3 +  3.1  12  31.3 ±  3.1  0 
D  SIS +  C  DNP-lysine-treated Tt,,  14.4 ±  2.2§  68  16.0 +  2.611  45 
E  SIS +  C  DNPn-MGG-treated To.  ND¶  17.8 ±  2.311  40 
F  SIS +  C  NIPg-MGG-treated Tt,H  ND  29.9 ±  3.0  0 
BALB/c mice were sensitized with DNFB on days 0 and  1, and immune LN cells  harvested on day 4. 
The cells  were resuspended in  RPMI  1640 medium at  10  s cells/ml and  treated  with  1 #g/ml  lysine, 
DNP-lysine, DNPn-MGG, or NIPa-MGG. After washing, these cells were used to adsorb 2 ml of 1:2 SIS 
for 30  min at  4°C.  Freshly prepared DNFB-immune LN cells  were then treated with  the adsorbed or 
unadsorbed SIS plus C  and transferred to normal recipients. The recipients were ear challenged with 
DNFB, and increased ear swelling was measured 24 h later. 
* See footnote in Table I. 
:~ Normal mouse serum. 
§ P<  0.001. 
II P< 0.01. 
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by only 41%  (group  B  vs.  A).  Nevertheless, adsorption  of this  serum with lysine- 
treated immune LN cells completely removed the inhibitory activity (group C vs. A), 
and this adsorption was blocked by treating the immune LN cells with either DNP- 
lysine or DNPn-MGG  (groups D  and E). However, treating the immune cells with 
NIPg-MGG had no effect as these cells completely adsorbed the inhibitory activity of 
the  SIS  (group  F).  These  results  indicate that  DNP-lysine  and  the  anti-idiotypic 
antibodies compete for the same binding sites on the DNFB-immune T  cells. 
Discussion 
Exactly how T  cells "see" antigen still is poorly understood. It seems clear that for 
activation of T  cells, the cells must interact with antigen in the context of certain 
MHC determinants expressed on the surface of antigen-presenting cells or target cells 
(7). The molecular nature of this interaction, i.e.,  the type(s) of receptor(s)  used by 
the T  cells, is unknown. In the present study, I have investigated the first phase of T 
cell-antigen interaction by treating DNFB-immune T  cells in vitro with free hapten 
or hapten-protein conjugates. The effect(s) of this treatment was measured by testing 
the ability of the treated cells to transfer CS  to DNFB  into na'/ve recipients. The 
experimental results establish the following points: (a) incubation of DNFB-immune 
LN cells or purified T  cells in vitro with E-DNP-L-lysine or DNP-protein conjugates 
inhibits, in a  dose-dependent way, the transfer of CS;  (b)  the inhibition is hapten 
specific and is not due to toxic effects of the hapten; (c) the inhibition is not mediated 
by activation of suppressor  cells;  (d)  inhibition of the T  cells by hapten  in  vitro, 
presumably reflecting their interaction, is rapid and temperature independent but 
requires divalent cations; (e) inhibition is reversed by incubating the treated cells for 
1 h in vitro in hapten-free medium. If these cells are retreated with hapten, transfer 
of immunity is again blocked; and (f) hapten-treated T  cells are unable to adsorb 
specific anti-idiotype antibody, and this inhibition of adsorption is hapten specific. 
CS to DNFB is mediated by Ia- T  cells (Toll)  (27). The finding here that transfer 
of CS  by  purified,  Ia-  T  cells,  carefully  monitored  for  macrophage  and  B  cell 
contamination, is blocked by monovalent hapten indicates that the Ton cells interact 
with the hapten. This is supported by the experiments which showed that activation 
of suppressor cells was not responsible for the inhibition. Thus, it appears that the 
inhibition of transfer of immunity is  due to direct  interaction of the effector Tt,  H 
population with the hapten and does not require or involve other cell types. 
These findings differ from most other studies that have attempted to block T  cell 
function with free antigen.  For example, lysis of chromium-labeled target cells by 
virus- or hapten-specific cytotoxic T  cells is not inhibited by unmodified cold target 
cells, virus-infected, or hapten-labeled allogeneic cells or by addition of free hapten 
(18, 20, 22, 26). Similarly, free antigen does not inhibit T cell proliferation in vitro or 
the binding of immune T  cells to antigen-pulsed macrophages (19, 21, 23-25). These 
negative findings are somewhat surprising in light of studies that have shown T  cell 
binding  of soluble  radiolabeled  antigen  (34-37).  It  is  difficult  to  reconcile  these 
apparently contradictory results, although it is  possible that  the T  cells that  bind 
soluble  radiolabeled  antigen  do  not  belong  to  the  same  functional  subset  being 
stimulated or analyzed. Alternatively, the closed, in vitro conditions used to measure 
most T  cell  functions and  that  are  almost  always optimized, may so  favor T  cell 
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difficult.  In other words,  if only a  limited number of contacts  (one or two perhaps) 
between the T  cell and antigen-presenting cell or target cell are required for stable T 
cell binding and activation, these interactions may occur with time in vitro even in 
the presence of a  large excess of antigen.  Thus, our ability to inhibit CS by treating 
T  cells with monovalent hapten may reflect, in part, the fact that we test the function 
of the cells in vivo rather than in vitro. Indeed, previous studies by Kantor (38)  and 
Leskowitz  and Jones  (39)  have  shown  that  delayed  hypersensitivity  reactions  are 
inhibited  either  by  treating  cells  in  vitro  with  highly  substituted  hapten-protein 
conjugates  and  then  transferring  the  cells,  or  by  injecting  immune  animals  with 
hapten-amino acid or hapten-protein conjugates. 
The interaction of T  cells with hapten in vitro, as measured by inhibition of trans- 
fer of immunty, is rapid, temperature independent,  and requires divalent cations in 
the  incubation  medium.  Furthermore,  the  inhibition  is  reversed  by incubating  the 
treated cells for 1 h  in hapten-free medium  (see below). Our finding that  15-30 min 
incubation time is required to achieve inhibition of transfer is in agreement with other 
reports  that  have  investigated  T  cell  binding  of radiolabeled  antigen  (34,  36,  37). 
However,  these  studies  have  found  that  significant  binding  occurs  only  at  37°C, 
whereas our results indicate that the temperature of incubation  has no effect on the 
level of inhibition  caused by the hapten.  At present we have no explanation  for this 
difference.  The  requirement  for divalent  cations  is  of particular  interest  since  this 
aspect has been studied  in a  variety of other systems. For example, divalent cations 
have been shown to be required for adherence of cytotoxic T  cells to target cells (40), 
for antigen-independent  and  antigen-dependent  binding  of lymphocytes to  macro- 
phages  (41,  42),  and  for maintenance  of antigen-dependent  binding  of-T  cells  to 
macrophages  (42).  It  has  been  suggested  that  divalent  cations  serve  to  form  ionic 
bridges between cells,  thus  providing stable interaction  at  the membrane interface. 
The results presented  here,  however, indicate  that  divalent  cations are required  for 
the inactivation of TDH cells by monovalent DNP-lysine without the participation of 
other cell types. The precise role the cations play in this process is unknown;  it seems 
unlikely to involve ionic bridges between cells. One possible alternative explanation 
is that they serve to stabilize the antigen receptor in the T  cell membrane, perhaps by 
maintaining the proper stereoconfiguration of subunits. This effect would be similar 
to  Ca+*-dependent  antigen-antibody  reactions  that  are  due  to  antibodies  directed 
against determinants formed and/or maintained by Ca++-induced alterations of the 
antigen  (43).  We are unaware of any studies of the divalent cation requirements for 
binding of radiolabeled antigen to T  cells. We are currently studying this and other 
aspects of the hapten-T cell interaction. 
The reversible nature of the hapten-inhibition in vitro at first presented a paradox 
since  the  inhibition  is  still  present  24  h  after  the  washed  cells  are  transferred 
intravenously to nai've recipients. We believe, however, that the situation is clarified 
by our  recent  experiments  which  show  that  addition  of serum  to  the  incubation 
medium  maintains  the  inhibited  state.  It  appears that  high  protein  concentration, 
i.e., 20% or more FCS, favors the continued association of the hapten with the T  cells, 
whereas low or no protein favors dissociation. Thus intravenously injected cells would 
be  suspended  in  the  plasma  equivalent  of  100%  serum  that  would  maintain  the 
hapten binding and would account for the inhibited response. 
The experiments that showed hapten-specific blocking of T  cell adsorption of anti- JOHN  W.  MOORHEAD  1823 
idiotype  antibody  provide critical  information  with  respect  to  the  mechanism  of 
hapten-inhibition of transfer of immunity. These results indicate that the hapten and 
the anti-idiotype antibody compete for the same site on the TDa cell. Since both of 
these reagents are hapten specific in their effect, this site is most likely the antigen- 
specific receptor for DNP. Krammer (44) has reported similar findings for alloantigen- 
binding T  cells. It follows then that the inhibition of transfer of CS is due to DNP- 
binding to the hapten-specific receptor on the T  cell.  It  is likely that  this binding 
prevents the T  cells from interacting with  immunogenic forms of the  hapten,  i.e., 
DNP plus MHC determinants, at the skin test site. This binding may be of relatively 
low affinity since the inhibition is reversed by incubating the treated cells in vitro for 
1  h  in  hapten-free medium.  We  believe this  reversal is  due  to dissociation of the 
hapten rather than shedding of receptors, because it occurs at 4°C and the cells are 
inhibited  again  by  reincubation  with  hapten.  It  is  unlikely  that  any  significant 
receptor shedding or re-expression would occur at 4°C. 
Finally, in a recent article discussing T  cell recognition of antigen, it was suggested 
that five criteria be met before T  cells could be characterized as hapten specific (17). 
Although  these criteria were written with respect  to activation of T  ceils, they are 
equally applicable to inhibition of T  cells and are restated in this context as follows: 
T  cells may be characterized as hapten specific if (a) cells are inhibited by the same 
hapten on different carriers; (b) carrier alone does not inhibit the cells; (c) a different 
hapten on the same carrier does not inhibit the ceils; (d)  free hapten can inhibit the 
response; and (e) cells are inhibited by the hapten coupled via spacer molecules to the 
carrier. The results presented here satisfy the first four of these five criteria and so the 
T  cells that mediate CS to DNFB can be termed hapten specific. Furthermore, these 
results  provide  strong  evidence  that  in  this  hapten-specific  TDa  population,  and 
regardless of other receptors, antigen recognition occurs via a receptor specific for the 
hapten DNP. These findings make the altered self model less  likely, unless the one 
receptor that this model proposes and that is specific for a neoantigenic determinant 
still can recognize hapten alone. 
Summary 
Experiments were done to investigate the nature of the antigen receptor on lymph 
node (LN) T  cells from mice sensitized to 2,4-dinitrofluorobenzene (DNFB). LN cells 
or purified T  cells were treated in vitro with monovalent or different multivalent 2,4- 
dinitrophenol (DNP)  ligands. The effect of this treatment was measured by testing 
the  ability  of the  cells  to  transfer  contact  sensitivity  (CS)  to  DNFB  into  na'ive 
recipients. We found that treatment of the T  cells in vitro with either ~-DNP-L-lysine 
or DNP-protein conjugates inhibits the transfer of CS in a dose-dependent way. The 
inhibition  is  hapten specific and  is  not  mediated  by activation of suppressor cells. 
Inhibition of the T  cells by hapten  in vitro is  rapid  (15-30 min)  and  temperature 
independent but requires divalent cations in the treatment medium. In addition, it 
was  found  that  hapten-treated  T  cells  are  unable  to  adsorb  specific anti-idiotype 
antibody, and this inhibition of adsorption is hapten specific. Collectively, these data 
indicate that DNFB-immune T  cells express a  receptor specific for the hapten DNP 
and  provide evidence that  supports a  two-receptor model for T  cell recognition of 
antigen. 1824  HAPTEN  INItlBITION OF  DNFB-IMMUNE  T  CELLS 
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